Characterization of the renal pharmacology of HP-522, a loop diuretic with uricosuric activity.
D000818:Animals; D004285:Dogs; D004976:Ethacrynic Acid / Q000494:pharmacology; D005260:Female; D005665:Furosemide / Q000494:pharmacology; D006016:Glycolates / Q000494:pharmacology*; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D007684:Kidney Tubules / Q000187:drug effects*; D008138:Loop of Henle / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009994:Osmolar Concentration; D010080:Oxazoles; D002679:Pan troglodytes; D012964:Sodium / Q000378:metabolism; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014667:Vasopressins / Q000494:pharmacology
D006016:Glycolates; D010080:Oxazoles; D006852:Hydrochlorothiazide; D014667:Vasopressins; D014527:Uric Acid; C029277:brocrinat; D005665:Furosemide; D012964:Sodium; D004976:Ethacrynic Acid